Earkart Ltd.
BBSE:EARKART125.80
INR
+0.80
(+0.64%)
Earkart Ltd.
BSE:EARKART
(Bombay Stock Exchange)
Recent
price
125.80
P/E
ratio
30.10
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Earkart Ltd. is an India-based hearing health technology and medical equipment company that operates an integrated hearing care platform connecting hearing care professionals, medical clinics, and patients with hearing aid manufacturers and diagnostic solutions. Founded in 2021 and headquartered in Noida, Uttar Pradesh, India, the company operates across the healthcare equipment, audiological devices, and digital health sectors. Earkart's core product and service portfolio comprises digital hearing aids, including Behind-the-Ear (BTE), Receiver-in-Canal (RIC), In-the-Ear (ITE), Completely-in-Canal (CIC), and Invisible-in-Canal (IIC) devices from leading global brands as well as proprietary hearing solutions; diagnostic audiological hardware, encompassing portable audiometers, digital video otoscopes, acoustic impedance meters, and automated hearing screening equipment; hearing care accessories and maintenance consumables, including rechargeable lithium-ion battery charging cases, replacement ear molds, silicone ear domes, wax guards, and dehumidifying drying kits; and digital health and practice management software, offering cloud-based audiometry data management, remote hearing aid programming, tele-audiology consultation tools, and clinic inventory procurement systems. The company primarily serves audiologists, ear-nose-throat (ENT) clinics, retail hearing care dispensaries, and end-consumer patients across Tier-1, Tier-2, and Tier-3 urban and semi-urban markets throughout India. In recent corporate developments, Earkart completed its public listing on the BSE SME platform under the ticker symbol EARKART; expanded its proprietary telemedicine and remote audiometry infrastructure to enable decentralized hearing device calibration; entered strategic distribution partnerships with international audiology device manufacturers to broaden its institutional product catalog; secured growth funding rounds to accelerate nationwide clinical network expansion; and launched an indigenous portfolio of affordable, AI-assisted hearing screening devices designed for decentralized community healthcare and enterprise occupational safety screening.